|
- American Society of Clinical Oncology - ASCO
ASCO org has a new look and feel, making it easier than ever to find premier oncology research from ASCO Meetings and Journals, and offering customized recommendations for signed-in users Explore the site using the navigation menu above or the site search
- About ASCO - ASCO
About ASCO Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer Overview
- Annual Meeting - ASCO - American Society of Clinical Oncology
Were you unable to attend the 2025 ASCO Annual Meeting? Access all five days of practice-changing science, cutting-edge research, and meeting content by purchasing the slides and videos
- Program - ASCO
The 2025 ASCO Annual Meeting is The Place to Be Learn more about the sessions, speakers, and science that will be presented at this year's meeting below
- ASCO Meetings
ASCO offers premier scientific events for oncology professionals, patient advocates, industry representatives, and major media outlets worldwide
- Meetings - ASCO
Learn more about ASCO's full slate of educational and scientific meetings Annual Meeting Best of ASCO ASCO Breakthrough Abstract Submissions ASCO Quality Care Symposium ASCO Gastrointestinal Cancers Symposium ASCO Genitourinary Cancers Symposium Joint Sessions Endorsements
- Practice Patients - ASCO
ASCO provides exemplary education and resources to support oncology practices and promote the delivery of high-quality, high-value cancer care
- Abstracts - ASCO
2025 ASCO Annual Meeting Long-term outcomes and overall survival (OS) for zanidatamab + chemotherapy in HER2-positive (HER2+) advanced or metastatic gastroesophageal adenocarcinoma (mGEA): 4-year follow-up of a phase 2 trial
|
|
|